Bionor Immuno Release: Researchers Find That Vacc-4x Therapeutic Peptide-Based HIV Vaccine Increases CD4 T-Cells in Chronically Infected HIV-1 Patients on Antiretroviral Therapy (ART)
10/21/2009 11:16:15 AM
More...
|
Bionor Immuno Welcomes Renowned Virologist Robert Redfield, MD to Its Clinical Advisory Board
10/19/2009 10:45:34 AM
More...
|
Norwegian Research Council Names Bionor Immuno "Most Innovative Company of the Year"
12/5/2008 8:27:45 AM
More...
|
Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization Program with Start of a Phase IIb Trial in U.S. and Europe
8/5/2008 9:17:06 AM
More...
|